Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Equipment
  3. australia
  4. tumor cells
Show results for
Products
Services
Software
Applications

Companies


Refine by
Locations
Back to All Locations

  • Australasia
  • Australia
Brands

  • medchemexpress
  • systimmune
  • cartherics
  • eutilex
  • stanford chemicals
View all brands
Applications

  • Solution for Clinical Trials
  • Solution for Access to Investigational Medicines
  • Diagnostic Solutions for Lung Cancer
  • Liquid Biopsy Solutions for Breast Cancer
  • Diagnostic Solutions for Colorectal Cancer
  • Radioactive Drugs for Diagnostics
  • Radioactive Drugs for Therapeutics
  • Drug Dolution for Liver Metastases
  • Drug Dolution for Gastric Cancer
  • microbiota for Clinical Studies
  • Actionable Molecular Diagnostic System for Physicians
  • Intraoperative Radiation Therapy (IORT) System - Electron Therapy for Skin Cancer
  • Intraoperative Radiation Therapy (IORT) System for Flash Radiotherapy
  • Intraoperative Radiation Therapy (IORT) System for Pancreatic Cancer Treatment
  • Intraoperative Radiation Therapy (IORT) System for Breast Cancer Treatment
  • Intraoperative Radiation Therapy (IORT) System for Single-Fraction APBI
  • Intraoperative Radiation Therapy (IORT) System for Surgical Oncologists
  • Intraoperative Radiation Therapy (IORT) System for Radiation Oncologists
  • Intraoperative Radiation Therapy (IORT) System for Hospital Administrators

Tumor Cells Equipment & Supplies In Australia

1,187 equipment items found
In AustraliaAvailable In AustraliaNear Australia

GenoCTC - Model Ver.3 - Circulating Tumor Cell Isolator

GenoCTC - Model Ver.3 - Circulating Tumor Cell Isolator

Manufactured by:GENCURIX   based inGuro-gu, SOUTH KOREA
CTCs(Circulating Tumor Cells) are cancer cells found in blood during metastasis. Being very rare, with one CTC per one billion hematopoietic cells, highly specific and sensitive technologies are imperative for their isolation. Geno CTC ver.3 allow high throughput and more accurate separation of CTCs from whole blood. ...
CONTACT SUPPLIER

Rarecells ISET - Isolation by SizE of Tumor Cells Technology

Rarecells ISET - Isolation by SizE of Tumor Cells Technology

Manufactured by:Rarecells Diagnostics SAS   based inParis Cedex 06, FRANCE
ISET, Isolation by SizE of Tumor Cells, is based on the antibody-independent whole blood filtration approach for CTCs and micro-emboli isolation. The solution relies on the larger size of all types of CTCs as compared to the majority of leukocytes. ISET system successfully captures CTCs that are presenting, by definition, heterogeneous phenotypic ...
CONTACT SUPPLIER

Pinaka - Model 360 - Theranostic Profiling Technology for Circulating Tumor Cells

Pinaka - Model 360 - Theranostic Profiling Technology for Circulating Tumor Cells

Manufactured by:Datar Cancer Genetics   based inGuildford, UNITED KINGDOM
Pinaka™ is an advanced non-invasive blood test which provides therapeutically relevant information via a safe, simple and quick blood draw. Pinaka™ evaluates blood sample to detect ‘Circulating Tumor Cells’ (CTCs), which are cancer cells that escape from the tumor and enter the blood stream. Pinaka™ ...
CONTACT SUPPLIER

Txinno Bioscience - Anti-Cancer Treatments Pipeline

Txinno Bioscience - Anti-Cancer Treatments Pipeline

Manufactured by:TxinnoBioscience Inc.   based inYongin-si, SOUTH KOREA
Txinno Bioscience is developing anti-cancer treatments focused on two intertwined aspects of physiology of tumor tissue. The first one is defined as tumor-intrinsic factors which are either genes or signaling pathways of tumor cells to directly control tumor cell proliferation or survival. ...
CONTACT SUPPLIER

Model ES004 - Antibody Targeting Pan-Allele Signal-Regulatory Protein Alpha (Sirpa)

Model ES004 - Antibody Targeting Pan-Allele Signal-Regulatory Protein Alpha (Sirpa)

Manufactured by:Elpiscience   based inShanghai, CHINA
ES004 is a potentially best-in-class antibody targeting pan-allele signal-regulatory protein alpha (SIRPα). SIRPα is an inhibitory receptor expressed only on myeloid cells and dendritic cells. Binding of CD47 to SIRPα delivers a “don’t eat me” signal to suppress phagocytosis. Tumor cells ...
CONTACT SUPPLIER

Adaptimmune - Model ADP-A2M10 (MAGE-A10) - T-Cell Therapy Pipeline

Adaptimmune - Model ADP-A2M10 (MAGE-A10) - T-Cell Therapy Pipeline

Manufactured by:Adaptimmune LLC   based inPhiladelphia, PENNSYLVANIA (USA)
Our ADP-A2M10 (MAGE-A10) T-cell therapy is directed to a member of the MAGE family of cancer testis antigens expressed in a number of solid tumor cell types. Any expression in cancer is often associated with higher grade tumors. Please note that the two trials with ADP-A2M10 are now closed for ...
CONTACT SUPPLIER

MedChemExpress - Model Sialyl Lewis A - 92448-22-1

MedChemExpress - Model Sialyl Lewis A - 92448-22-1

Manufactured by:MedChemExpress LLC (MCE)   based inMonmouth Junction, NEW JERSEY (USA)
Sialyl Lewis A (SLeA) is a carbohydrate-type antigen that can serve as a tumor marker, with upregulation observed in various tumor cells such as cervical cancer, human pancreatic cancer, and colon cancer cells. Sialyl Lewis A is involved in the migration and adhesion of tumor cells. Additionally, ...
CONTACT SUPPLIER

Challen - Model (FITC) - CD3 - Detection Reagent

Challen - Model (FITC) - CD3 - Detection Reagent

Manufactured by:Beijing Challen Biotechnology Co., Ltd.   based inDaxing District, CHINA
Scope of application: Detect the expression of CD3 in human biological specimens and provide doctors with auxiliary information for diagnosis. Testable items: detection of lymphocyte subpopulations, regulatory T cells, PD-1, expressed in blast cells of acute T-ceii leukemia and tumor cells of mature T-ceii ...
CONTACT SUPPLIER

Adaptimmune - Model ADP-A2M4 (MAGE-A4) - Spear T-Cell Therapy

Adaptimmune - Model ADP-A2M4 (MAGE-A4) - Spear T-Cell Therapy

Manufactured by:Adaptimmune LLC   based inPhiladelphia, PENNSYLVANIA (USA)
Our ADP-A2M4 (MAGE-A4) SPEAR T-cell therapy is directed to a member of the MAGE family of cancer testis antigen expressed in a number of solid tumor cell types. The MAGE- A4 antigen is among the most commonly expressed cancer-testis antigens. We are conducting various trials with the ADP-A2M4 SPEAR T-cell in various solid ...
CONTACT SUPPLIER

Creative Peptides - Model R0815 - Z-DEVD-FMK

Creative Peptides - Model R0815 - Z-DEVD-FMK

Manufactured by:Creative Peptides   based inNew York, NEW YORK (USA)
We are dedicated to offering custom peptide synthesis, process development, GMP manufacturing as well as catalog products for customers in industry and research area. We provide Z-DEVD-FMK. Z-DEVD-FMK is a cell-permeable, irreversible inhibitor of Caspase-3/CPP32. It is also an irreversible inhibitor of Caspase-6, Caspase-7, caspase-8, and Caspase-10. Z-DEVD-FMK has been shown to ...
CONTACT SUPPLIER

MedChemExpress - Model Gefitinib hydrochloride - 184475-55-6

MedChemExpress - Model Gefitinib hydrochloride - 184475-55-6

Manufactured by:MedChemExpress LLC (MCE)   based inMonmouth Junction, NEW JERSEY (USA)
Gefitinib hydrochloride (ZD1839 hydrochloride) is a potent, selective and orally active EGFR tyrosine kinase inhibitor with an IC50 of 33 nM. Gefitinib hydrochloride selectively inhibits EGF-stimulated tumor cell growth (IC50 of 54 nM) and that blocks EGF-stimulated EGFR autophosphorylation in tumor cells. Gefitinib hydrochloride ...
CONTACT SUPPLIER

MedChemExpress - Model Gefitinib - 184475-35-2

MedChemExpress - Model Gefitinib - 184475-35-2

Manufactured by:MedChemExpress LLC (MCE)   based inMonmouth Junction, NEW JERSEY (USA)
Gefitinib (ZD1839) is a potent, selective and orally active EGFR tyrosine kinase inhibitor with an IC50 of 33 nM. Gefitinib selectively inhibits EGF-stimulated tumor cell growth (IC50 of 54 nM) and that blocks EGF-stimulated EGFR autophosphorylation in tumor cells. Gefitinib also induces autophagy and cell ...
CONTACT SUPPLIER

MedChemExpress - Model Gefitinib dihydrochloride - 184475-56-7

MedChemExpress - Model Gefitinib dihydrochloride - 184475-56-7

Manufactured by:MedChemExpress LLC (MCE)   based inMonmouth Junction, NEW JERSEY (USA)
Gefitinib (ZD 1839) dihydrochloride is a potent, selective and orally active EGFR tyrosine kinase inhibitor with an IC50 of 33 nM. Gefitinib dihydrochloride selectively inhibits EGF-stimulated tumor cell growth (IC50 of 54 nM) and blocks EGF-stimulated EGFR autophosphorylation in tumor cells. Gefitinib dihydrochloride also ...
CONTACT SUPPLIER

Zymeworks - Model ZW49 - Bispecific Antibody Drug Conjugate (ADC)

Zymeworks - Model ZW49 - Bispecific Antibody Drug Conjugate (ADC)

by:Zymeworks Inc   based inVancouver, BRITISH COLUMBIA (CANADA)
ZW49 combines the unique design of zanidatamab with a proprietary cytotoxin and cleavable linker. ZW49 delivers a novel auristatin (cell-killing compound) to tumor cells by taking advantage of the enhanced antibody-HER2 internalization of zanidatamab. ...
CONTACT SUPPLIER

Stanford Chemicals - Model 040-000-285 - Losartan Potassium, CAS 124750-99-8

Stanford Chemicals - Model 040-000-285 - Losartan Potassium, CAS 124750-99-8

Manufactured by:Stanford Chemicals Company   based inLake Forest, CALIFORNIA (USA)
It is a nucleoside analogue, with effective antiviral activity, with EC50s of 74 nM for SARS-CoV and MERS-CoV in HAE cells, and 30 nM for murine hepatitis virus in delayed brain tumor cells. Remdesivir is highly effective in the control of 2019-nCoV (COVID-19) infection in ...
CONTACT SUPPLIER

Sumitomo - Model TP-1454 - Investigational Oral Pyruvate Kinase M2 Isoform (PKM2) Activator

Sumitomo - Model TP-1454 - Investigational Oral Pyruvate Kinase M2 Isoform (PKM2) Activator

by:Sumitomo Pharma Oncology, Inc.   based inCambridge, MASSACHUSETTS (USA)
TP-1454 is an investigational oral pyruvate kinase M2 isoform (PKM2) activator.44 This activation is thought to starve cancer cells of important molecular building blocks, inhibiting tumor cell proliferation, and enhancing antitumor ...
CONTACT SUPPLIER

Liposome - Model NanoX - Targeted Delivery Technology

Liposome - Model NanoX - Targeted Delivery Technology

by:Taiwan Liposome Company, Ltd. (TLC)   based inNangang Distric, TAIWAN
NanoX® technology uses nanoparticles coated with the compound polyethylene glycol to reduce uptake by phagocytic cells of the immune system. This prolongs circulation in the body, allowing a drug to predominantly accumulate at particular disease sites such as tumors. Therapies based on NanoX® technology can also make use of additional molecular coatings ...
CONTACT SUPPLIER

LifeTein - Macrophage Colony Stimulating Factor (M-CSF)

LifeTein - Macrophage Colony Stimulating Factor (M-CSF)

Manufactured by:LifeTein, LLC    based inHillsborough, NEW JERSEY (USA)
Macrophage Colony Stimulating Factor (M-CSF), also known as CSF-1, can be produced by a number of cells, including fibroblasts, monocytes, activated macrophages, secretory epithelial cells of the endometrium, endothelial cells activated by LPS or cytokines, and bone marrow stromal cells. In addition to its namesake activity, ...
CONTACT SUPPLIER

MedChemExpress - Model Lornoxicam - 70374-39-9

MedChemExpress - Model Lornoxicam - 70374-39-9

Manufactured by:MedChemExpress LLC (MCE)   based inMonmouth Junction, NEW JERSEY (USA)
Lornoxicam exhibits good inhibitory effects on both COX-1 and COX-2 (COX-1: IC50=0.005 μM; COX-2:IC50=0.008 μM) and inhibits the production of NO by iNOS (IC50=65 μM) and the proinflammatory cytokine IL-6 (IC50=54 μM). Lornoxicam also inhibits tumor cell proliferation and migration and induces tumor cell apoptosis. Lornoxicam can ...
CONTACT SUPPLIER

Eutilex - Model EU301(MVR CAR-T) - Relapsed and Refractory B Cell Leukemia and B Cell Lymphoma

Eutilex - Model EU301(MVR CAR-T) - Relapsed and Refractory B Cell Leukemia and B Cell Lymphoma

Manufactured by:Eutilex Co.,Ltd.   based inSeoul, SOUTH KOREA
MVR CAR-T can be used against HLA-DR positive cancer, as well as B cell malignancy. The epitopes recognized by HLA-DR are not shed or internalized, enabling stable binding to human lymphoma cells. MVR CAR-T can also be used in patients who relapse after CD19 CAR-T treatment. Reduction of cytokine secretion due to selective killing of tumor ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT